HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Protein kinase A-dependent step(s) in hepatitis C virus entry and infectivity.

Abstract
Viruses exploit signaling pathways to their advantage during multiple stages of their life cycle. We demonstrate a role for protein kinase A (PKA) in the hepatitis C virus (HCV) life cycle. The inhibition of PKA with H89, cyclic AMP (cAMP) antagonists, or the protein kinase inhibitor peptide reduced HCV entry into Huh-7.5 hepatoma cells. Bioluminescence resonance energy transfer methodology allowed us to investigate the PKA isoform specificity of the cAMP antagonists in Huh-7.5 cells, suggesting a role for PKA type II in HCV internalization. Since viral entry is dependent on the host cell expression of CD81, scavenger receptor BI, and claudin-1 (CLDN1), we studied the role of PKA in regulating viral receptor localization by confocal imaging and fluorescence resonance energy transfer (FRET) analysis. Inhibiting PKA activity in Huh-7.5 cells induced a reorganization of CLDN1 from the plasma membrane to an intracellular vesicular location(s) and disrupted FRET between CLDN1 and CD81, demonstrating the importance of CLDN1 expression at the plasma membrane for viral receptor activity. Inhibiting PKA activity in Huh-7.5 cells reduced the infectivity of extracellular virus without modulating the level of cell-free HCV RNA, suggesting that particle secretion was not affected but that specific infectivity was reduced. Viral particles released from H89-treated cells displayed the same range of buoyant densities as did those from control cells, suggesting that viral protein association with lipoproteins is not regulated by PKA. HCV infection of Huh-7.5 cells increased cAMP levels and phosphorylated PKA substrates, supporting a model where infection activates PKA in a cAMP-dependent manner to promote virus release and transmission.
AuthorsMichelle J Farquhar, Helen J Harris, Mandy Diskar, Sarah Jones, Christopher J Mee, Søren U Nielsen, Claire L Brimacombe, Sonia Molina, Geoffrey L Toms, Patrick Maurel, John Howl, Friedrich W Herberg, Sven C D van Ijzendoorn, Peter Balfe, Jane A McKeating
JournalJournal of virology (J Virol) Vol. 82 Issue 17 Pg. 8797-811 (Sep 2008) ISSN: 1098-5514 [Electronic] United States
PMID18579596 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antigens, CD
  • CLDN1 protein, human
  • Claudin-1
  • Isoenzymes
  • Membrane Proteins
  • Receptors, Virus
  • SCARB1 protein, human
  • Scavenger Receptors, Class B
  • Luciferases
  • Cyclic AMP-Dependent Protein Kinases
Topics
  • Antigens, CD (analysis)
  • Carcinoma, Hepatocellular (metabolism, pathology)
  • Cell Line
  • Cell Line, Tumor
  • Claudin-1
  • Cyclic AMP-Dependent Protein Kinases (metabolism)
  • Fluorescent Antibody Technique, Indirect
  • Genes, Reporter
  • Hepacivirus (genetics, pathogenicity, physiology)
  • Humans
  • Isoenzymes (metabolism)
  • Kidney (cytology)
  • Liver Neoplasms (metabolism, pathology)
  • Luciferases (metabolism)
  • Membrane Proteins (analysis)
  • Plasmids
  • Receptors, Virus (analysis, physiology)
  • Scavenger Receptors, Class B (analysis)
  • Transfection
  • Virus Internalization

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: